12 February 2024
· Designation underscores the unmet need for medicines that can achieve functional cure in patients with chronic hepatitis B (CHB) GSK plc (LSE/NYSE: GSK) announced today that…
9 February 2024
9 February 2024 TESCO AGREES LONG-TERM STRATEGIC PARTNERSHIP WITH BARCLAYSTO PROVIDE CUSTOMERS WITH TESCO-BRANDED BANKING PRODUCTS AND SERVICES EXISTING TESCO BANKING OPERATIONS TO BE…
9th February 2024 S&U plc (“S&U” or “the Group”) TRADING STATEMENT AND NOTICE OF RESULTS S&U PLC, the specialist Motor and Property Finance…
9 February 2024 Victrex plc – AGM & Q1 Interim Management Statement ‘A soft start to FY 2024 – in line with guidance’ Victrex plc is…
8 February 2024
British American Tobacco p.l.c. Preliminary results for the year ended 31 December 2023 Building a Smokeless World Summary – Revenue down 1.3%, up 3.1%…
SSE PLC Q3 TRADING STATEMENT 8 FEBRUARY 2024 · Reaffirming FY24 adjusted earnings per share guidance of more than 150p. · Focus on delivery throughout challenging…
2023 Full Year Results Implementing Growth Action Plan at pace Underlying performance GAAP measures (unaudited) 2023 vs 2022 …
Strong growth and pipeline momentum with three new medicines approved since the third quarter Revenue and EPS summary FY 2023 Q4 2023 % Change…